Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress

Clinical islet allotransplantation has been successfully regulated as tissue/organ for transplantation in number of countries and is recognized as a safe and efficacious therapy for selected patients with type 1 diabetes mellitus. However, in the United States, the FDA considers pancreatic islets as...

Descripción completa

Detalles Bibliográficos
Autores principales: Witkowski, Piotr, Philipson, Louis H., Buse, John B., Robertson, R. Paul, Alejandro, Rodolfo, Bellin, Melena D., Kandeel, Fouad, Baidal, David, Gaglia, Jason L., Posselt, Andrew M., Anteby, Roi, Bachul, Piotr J., Al-Salmay, Yaser, Jayant, Kumar, Perez-Gutierrez, Angelica, Barth, Rolf N., Fung, John J., Ricordi, Camillo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772267/
https://www.ncbi.nlm.nih.gov/pubmed/35069442
http://dx.doi.org/10.3389/fendo.2021.789526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772267/
https://www.ncbi.nlm.nih.gov/pubmed/35069442
http://dx.doi.org/10.3389/fendo.2021.789526

Ejemplares similares